Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Endocrinology Endocrinology for November/December 2020 Oral steroids plus PPIs increase osteoporotic fracture risk in RA patients, Sac/val heart failure benefit extends to diabetes patients, Don’t miss cardiovascular risk factors in transgender patients, No link shown between thyroid dysfunction and heart failure, Denosumab favored over alendronate for BMD protection in glucocorticoid-induced osteoporosis, More must reads Endocrinology for September/October 2020 Menstrual irregularity appears to be predictor of early death, Dapagliflozin’s CKD performance sends heart failure messages, Higher glycemic time in range may benefit T2D patients, CagA-positive H. pylori patients at higher risk of osteoporosis, fracture, Obesity boosts risks in COVID-19 from diagnosis to death, More must readsEndocrinology for July/August 2020 Unexpected rosuvastatin-canagliflozin adverse effect reported, Postmenopausal use of estrogen alone lowers breast cancer cases, deaths, Cleaner data confirm severe COVID-19 link to diabetes, hypertension, Abaloparatide shows no effect on cardiovascular risk in postmenopausal women, Cardiac CT scans can be used for osteoporosis screening, More must readsEndocrinology for May/June 2020 T2D plus heart failure packs a deadly punch, Increased hypothyroidism risk seen in young men with HS, Half of young adults with diabetes have diastolic dysfunction, Aldosterone-driven hypertension found with unexpected frequency, High-intensity exercise builds bone in older men, More must readsEndocrinology for March/April 2020 REPLENISH: Oral estradiol/progesterone slowed bone turnover as it cut VMS, Proximal fractures linked to higher mortality, High and low trauma yield similar future osteoporotic fracture risk, Fracture liaison services confer benefit on recurrent fracture risk, In gestational diabetes, early postpartum glucose testing is a winner, More must readsPages1 2 3 4 5 last »
